Cookies Policy

The website of the University of Cádiz uses its own and third-party cookies to carry out analysis of use and measurement of traffic, as well as to allow the correct functioning in social networks, and in this way to improve your browsing experience.

If you want to configure cookies, press the button Customize Cookies. You can also access the cookie settings at any time from the corresponding link in the footer.

For more information about cookies you can consult the Cookies policy from the website of the University of Cádiz.

Cookies customization

The website of the University of Cádiz uses its own and third-party cookies to carry out analysis of use and measurement of traffic, as well as to allow the correct functioning in social networks, and in this way to improve your browsing experience.

For more information about cookies you can consult the Cookies policy from the website of the University of Cádiz. You can also access the cookie settings at any time from the corresponding link in the footer.

You can configure the website cookies according to their purpose:

  • Statistical analysis

    Third-party cookies (Google Analytics) are used on this site that allow the number of users to be quantified anonymously (personal data will never be obtained to identify the user) and thus be able to analyze the use made by users of our service, in order to improve the browsing experience and offer our content optimally.

  • Social networks

    Third-party cookies are used on this website that allow the proper functioning of some social networks (mainly YouTube and Twitter) without using any personal data of the user.

UniversidaddeCádiz
HEAT-Net Meeting 2024 Frontiers in Neurodegeneration: from bench to bedside

Programme

HEAT-Net Meeting 2024

Frontiers in Neurodegeneration: from bench to bedside

 

Thursday September 5th

8:30 Coffee

 

9:00-9:10: Welcome from the organizing Committee, Dr. Manuel Rosety Dean of Medicine School from the University of Cadiz and the ViceChancellor of Research from the University of Cadiz.

 

Session 1 – Biomarkers for prediction and diagnostics

9:10-9:30: Christina Lill: Prediction of neurodegenerative diseases in the longitudinal EPIC cohort using a multi-omics approach

9:30-9:50: Alberto Lleó: Update on blood biomarkers in Alzheimer’s disease

9:50-10:10: Henrik Zetterberg: Update on biofluid-based biomarkers for non-Alzheimer’s neurodegenerative dementias

 

10:10-10:30 Discussion

 

Session 2 – What is new in genetics?

10:30-10:50: Lars Bertram: The role of short tandem repeats in Alzheimer’s disease genetics

10:50-11:10: Mikko Hiltunen: Functional characterization of Alzheimer’s disease-associated genetic variants in NPH biopsy samples

 

11:10-11:30: Discussion

 

Session 3 – Animal models for neurodegeneration

11:30-11:50: Christine von Arnim: Cognitive impairment in an obesity mouse model

11:50-12.10: Monica Garcia-Alloza: Blood-brain barrier and blood-retina barrier in AD- diabetes models

12:00-12:30: Clevio Nobrega: New players and targets in neurodegeneration: the case of spinocerebellar ataxias

 

12:30-12:50: Discussion

 

12:50-15:15: Poster session and Lunch

 

Session 4 – Brief talks

15.15-16.15: Brief talks by junior investigators

 

Session 5 – Keynote lecture

16.15-17.00: Brad Hyman: Testing assumptions about neurodegeneration in AD

17.00-17.15: Discussion

 


 

Friday September 6th

8:30: Coffee

 

Session 6 – Propagation and aggregation in neuroinflammation and neurodegeneration

9:00-9:20: Karin Danzer: Propagation mechanisms in PD and ALS models

9:20-9:40: Tiago Outeiro: Modeling and imaging protein aggregation in cells

9:40-10:00: Cintia Roodveldt: Novel signaling mechanisms in microglia-mediated neuroinflammation and implications for neurodegenerative diseases.

 

Session 7 – Synaptic pathology in neurodegeneration

10:00-10:20: Anna-Kaisa Haapasalo: Synaptic disturbances in frontotemporal dementia

10:20-10:40: Tara Spires-Jones: Synaptic tau – a tangled issue

10:40-11:00: Rafael Fernandez Chacon: Molecular pathophysiology of a synaptic co-chaperone in neurodegeneration

 

11:00-11:20: Discussion

 

Session 8 – Brief talks

11.20-12.30: Brief talks by junior investigators

 

12.30-15.00: Poster session and Lunch

 

Session 9 – Novel therapies

15:00-15:20: Martin Ingelsson: Development of immunotherapy for Parkinson’s disease

15:20-15:40: Teresa Gomez-Isla: New era and new challenges in the treatment of Alzheimer’s disease

 

15:40-16.00: Discussion

 

Session 10 – Keynote lecture

16:00-16:45: Brian Bacskai: In vivo imaging of cell and organelle specific pathophysiology in a mouse model of Alzheimer’s disease

16:45-17:05: Discussion

 

20:00: Dinner